Thompson Rahsaan 4
4 · ZEVRA THERAPEUTICS, INC. · Filed Jun 30, 2025
Insider Transaction Report
Form 4
Thompson Rahsaan
Chief Legal & ComplianceOther
Transactions
- Sale
Common Stock
2025-06-26$9.21/sh−24,000$221,004→ 42,666 total
Footnotes (2)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 03-27-2025
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.11 to $9.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.